SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-22-000087
Filing Date
2022-07-01
Accepted
2022-07-01 16:34:48
Documents
14
Period of Report
2022-06-30
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K optn-20220630.htm   iXBRL 8-K 37374
2 EX-99.1 avistastockholdersagreemen.htm EX-99.1 11800
6 GRAPHIC optn-20220630_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-22-000087.txt   222503

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20220630.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20220630_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20220630_pre.xml EX-101.PRE 13581
8 EXTRACTED XBRL INSTANCE DOCUMENT optn-20220630_htm.xml XML 11806
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 221061951
SIC: 2834 Pharmaceutical Preparations